Microfluidics Market Size Worth Around USD 62 BN by 2030

The global microfluidics market size is estimated to worth around USD 62 billion by 2030 and expanding growth at a CAGR of 16.5% during the forecast period 2021 to 2030.

Growing technological developments in diagnostic devices, rising incidence of chronic disorders, and surge in demand for microfluidics technology are all driving the growth of the microfluidics market. There have been significant technological developments in the present market.

Get the sample copy of report@ https://www.precedenceresearch.com/sample/1116

Microfluidics advancements are also allowing for the development of a cost-effective diagnostic device mass production method, and the pairing of smartphones with microfluidics is allowing for the deployment of point of care testing. This has broadened the scope of microfluidics device applications, which is projected to continue to grow in the coming future. The growing number of clinical trials for cell-based therapeutics is also driving the microfluidics market growth. Rapid demand for low volume sample analysis, in vitro diagnostics, high output screening approaches, and the development of innovative lab-on-a-chip technologies are all driving the microfluidics market expansion.

Report Highlights:

• Based on the material, the polydimethylsiloxane (PDMS) segment dominated the global microfluidics market in 2020 with highest market share. Among other polymers, polydimethylsiloxane (PDMS) has grown in prominence, notably in microfluidics devices and tools that require quick prototyping. This is attributed to the strong acceptance of these polymers among academic professionals, which is mostly due to the material’s ease of manufacturing and pricing.
• Based on the technology, the medical segment dominated the global microfluidics market in 2020 with highest market share. Microfluidics is getting a lot of traction in point of care devices for the diagnosis and detection of a wide range of ailments from cancer to infectious disorders.
• Based on the application, the lab-on-a-chip segment dominated the global microfluidics market in 2020 with highest market share. Lab-on-a-chip is suitable for molecular biology applications because it enables high detection speed while preserving the requisite sensitivity during amplification and detection procedures.
• North America is the largest segment for microfluidics market in terms of region. North America has a number of benefits such as government investment efforts and the provision of high-quality infrastructure for laboratory and clinical research. The rising government support for drug discovery research, increased research and development initiatives, and significant growth in the biotechnology and pharmaceutical industries are all contributing to the microfluidics market’s expansion.
• Asia-Pacific region is the fastest growing region in the microfluidics market. Due to increased government support for modern infrastructure and strong intellectual property rights ownership, the market for medical diagnostics, biosensing, and high data processing and screening is rising in Asia-Pacific region, which is driving the growth of the microfluidics market.

Ask here for customization@ https://www.precedenceresearch.com/customization/1116

Future of Microfluidics Market

Organ-on-a-chip systems can be utilized to investigate a wide range of biomedical phenomena in drug discovery, customized medicine, and toxicity testing. Microfluidics have been recently used in 3D cell culture to create microenvironments that facilitate tissue differentiation and mimic the tissue interface, mechanical microenvironments of live organisms, and spatiotemporal chemical gradients. Organ-on-a-chip model allow researchers to investigate human physiology in an organ-specific setting, allowing for the development of in vitro disease models and eventually replacing animal models in drug development and toxicity assessment. A lot of research investigations are being undertaken to examine the performance of microfluidic chips in pharmaceutical studies due to its potential.

COVID-19 Impact Analysis:

• The COVID-19 epidemic had a favorable impact on the microfluidics market. Rapid diagnostic tests, point of care diagnostics, and IVD devices that use microfluidics technology for drug discovery and COVID-19 testing are in high demand.
• To identify COVID-19, several major market players are concentrating on introducing quick antigen testing based on microfluidics technology.

Key Developments in the Marketplace:

• The LM-Pro linear motor proportional valves for ventilators were introduced by Parker-Hannifin Corporation in March 2020.
• The SARS CoV-2 standard was launched by Bio-Rad Laboratories Inc. in March 2020 to facilitate laboratory assay validation of COVID-19 testing. The FDA granted Germitec S.A. approval for the UV reprocessor in April 2019.
• Velcora Holding AB was acquired by IDEXX Corporation in July 2018. The company was able to strengthen its position in the worldwide microfluidics market as a result of this acquisition.
• Illumina declared its latest group of startup entities in June 2020, which will begin operations in conjunction with Illumina’s teams in San Francisco and London.
• The FDA approved Cepheid’s GeneXpert quick molecular diagnostic machines to test for the novel coronavirus in March 2020. Disposable cartridges pre-filled with the appropriate chemicals are used in the module, which are directed around test chambers utilizing microfluidics.
• Dolomite Microfluidics and MilliporeSigma teamed together in November 2020 to provide off the shelf NanoFabTx microfluidic device kits for the synthesis of nano and microparticles for drug research and controlled drug release.

Market Segmentation

By Material

• Glass
• Silicon
• PDMS
• Polymers
• Others

By Technology

• Non-Medical
• Medical
  • Gel Electrophoresis
  • PCR & RT-PCR
  • ELISA
  • Microarrays
  • Others

By Application

• Organs-on-chips
• Lab-on-a-chip
• Continuous Flow Microfluidics
• Acoustofluidics and Microfluidics
• Optofluidics and Microfluidics
• Electrophoresis and Microfluidics

By Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Click Here to View Full Report Table of Contents

Buy this Research Report@ https://www.precedenceresearch.com/checkout/1116

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333